In this study, we developed a new AMIGO2-specific antibody that does not react with AMIGO1 and AMIGO3, and compared the efficacy of the new antibody using the same tissue samples that previously reported a significant correlation between AMIGO2 expression in primary CRC tissue and liver metastasis [11]. Here, AMIGO1 is linked to colorectal carcinoma.